Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) EBITDA Margin (2018 - 2023)

Q32 Bio (QTTB) has 6 years of EBITDA Margin data on record, last reported at 469.68% in Q4 2023.

  • For Q4 2023, EBITDA Margin rose 383132.0% year-over-year to 469.68%; the TTM value through Sep 2024 reached 1408.28%, down 76219.0%, while the annual FY2025 figure was 31.45%, N/A changed from the prior year.
  • EBITDA Margin reached 469.68% in Q4 2023 per QTTB's latest filing, down from 419.47% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 3.79% in Q1 2021 and bottomed at 9304.81% in Q1 2019.
  • Average EBITDA Margin over 5 years is 3700.56%, with a median of 4145.07% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: plummeted -835743bps in 2019, then skyrocketed 620233bps in 2021.
  • A 5-year view of EBITDA Margin shows it stood at 4539.79% in 2019, then surged by 33bps to 3040.92% in 2020, then crashed by -38bps to 4192.64% in 2021, then decreased by -3bps to 4301.0% in 2022, then soared by 89bps to 469.68% in 2023.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 469.68% in Q4 2023, 419.47% in Q3 2023, and 226.99% in Q2 2023.